Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

California Institute for Regenerative Medicine

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 37
Average round size
info
The average size of a deal this fund participated in
$8M
Portfolio companies 34
Rounds per year 1.95
Lead investments 16
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.08
Exits 10
Key employees 3

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
Summary

In 2005 was created California Institute for Regenerative Medicine, which is appeared as Corporate Investor. The venture was found in North America in United States. The leading representative office of defined Corporate Investor is situated in the San Francisco.

Opposing the other organizations, this California Institute for Regenerative Medicine works on 35 percentage points more the average amount of lead investments. Considering the real fund results, this Corporate Investor is 71 percentage points more often commits exit comparing to other organizations. The top activity for fund was in 2017. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The increased amount of exits for fund were in 2013.

The overall number of key employees were 3.

Among the various public portfolio startups of the fund, we may underline Orchard Therapeutics, VistaGen Therapeutics, Sangamo Therapeutics Besides, a startup needs to be aged 11-15 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Clinical Trials, Medical Device. The fund has specific favorite in a number of founders of portfolio startups. If startup sums 3 or 4 of the founder, the chance for it to be financed is low.

The usual cause for the fund is to invest in rounds with 1 partaker. Despite the California Institute for Regenerative Medicine, startups are often financed by Sanderling Ventures, Malin Corporation, Johnson & Johnson Development Corporation. In the next rounds fund is usually obtained by W.L. Gore & Associates, Vivo Capital, Temasek Holdings.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of California Institute for Regenerative Medicine:
Typical Co-investors
California Institute for Regenerative Medicine is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after California Institute for Regenerative Medicine:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Aivi Invest -
Arcadian Investment Partners New York, New York, United States
Bank El Etihad Amman, Amman, Jordan
Be Angels Belgium, Louvain-la-neuve, Vlaams-Brabant
Disruptive Capital Finance England, London, United Kingdom
DMC Stratex Networks California, San Jose, United States
E Fund Management Co.,LTD. China, Hong Kong, Hong Kong Island
EnerNOC Boston, Massachusetts, United States
Food+Tech Connect New York, New York, United States
Higginbotham Strategic Investments -
Humanwell China, Hubei, Wuhan
Jumbo Sheen Group China, Guangdong, Shenzhen
Presight Capital New City, New York, United States
Rock Springs Capital Baltimore, Maryland, United States
Siddhivinayak Skyscrapers -
WANDA Group Beijing, Beijing, China
Yabeo Capital Bavaria, Bayern, Germany
Zhongyan Chuangxin Touzi China, Guangdong, Shenzhen

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent California Institute for Regenerative Medicine?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 37
Average round size 8M
Rounds per year 1.95
Peak activity year 2023
Lead investments 16
Follow on index 0.08
Exits 10
Crunchbase icon

Content report

The following text will be sent to our editors: